Literature DB >> 31071597

Narrative identity, rationality, and microdosing classic psychedelics.

Megan Webb1, Heith Copes2, Peter S Hendricks3.   

Abstract

BACKGROUND: Microdosing involves ingesting a small dose of a classic psychedelic (e.g., LSD and psilocybin) at regular intervals for prolonged periods. The practice is said to reduce anxiety, improve mood, and offer several creative and practical benefits to users. Using the narrative identity theoretical framework, our aim was to explore the experiences of those who microdosed classic psychedelics. Specifically, we sought to understand how and why they began microdosing and how they made sense of their actions in the context of their conventional lives.
METHODS: To understand the experiences of those who microdose classic psychedelics, we rely on data collected from semi-structured interviews with 30 people who had microdosed.
RESULTS: Participants saw themselves as conventional citizens who microdosed for rational and instrumental purposes. They emphasized the rationality of microdosing by discussing (1) the practicality of their procurement and administration processes, (2) the connection between their microdosing practice and their general awareness in health and wellness, and (3) the benefits of the practice.
CONCLUSION: Participants described their microdosing in the context of embracing traditional middle-class values. This created social distance between themselves and those who use drugs recreationally. While people who use drugs recreationally typically construct boundaries by distancing themselves from symbolic others (i.e., "crackheads," "meth heads," "junkies"), microdosers constructed boundaries by emphasizing connections to conventional citizens who embrace middle-class values. This connection to conventional citizens allows them to normalize their drug use and facilitates persistence.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  LSD; Microdosing; Narrative identity; Psilocybin; Qualitative analysis; Symbolic boundaries

Mesh:

Substances:

Year:  2019        PMID: 31071597     DOI: 10.1016/j.drugpo.2019.04.013

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


  8 in total

1.  Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls.

Authors:  Joseph M Rootman; Maggie Kiraga; Pamela Kryskow; Kalin Harvey; Paul Stamets; Eesmyal Santos-Brault; Kim P C Kuypers; Zach Walsh
Journal:  Sci Rep       Date:  2022-06-30       Impact factor: 4.996

2.  Psychedelic Microdosing: Prevalence and Subjective Effects.

Authors:  Lindsay P Cameron; Angela Nazarian; David E Olson
Journal:  J Psychoactive Drugs       Date:  2020-01-23

3.  Self-Rated Effectiveness of Microdosing With Psychedelics for Mental and Physical Health Problems Among Microdosers.

Authors:  Nadia R P W Hutten; Natasha L Mason; Patrick C Dolder; Kim P C Kuypers
Journal:  Front Psychiatry       Date:  2019-09-13       Impact factor: 4.157

4.  Adults who microdose psychedelics report health related motivations and lower levels of anxiety and depression compared to non-microdosers.

Authors:  Joseph M Rootman; Pamela Kryskow; Kalin Harvey; Paul Stamets; Eesmyal Santos-Brault; Kim P C Kuypers; Vince Polito; Francoise Bourzat; Zach Walsh
Journal:  Sci Rep       Date:  2021-11-18       Impact factor: 4.379

5.  Psilocybin microdosing does not affect emotion-related symptoms and processing: A preregistered field and lab-based study.

Authors:  Josephine Marschall; George Fejer; Pascal Lempe; Luisa Prochazkova; Martin Kuchar; Katerina Hajkova; Michiel van Elk
Journal:  J Psychopharmacol       Date:  2021-12-17       Impact factor: 4.153

6.  Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study.

Authors:  Carla Pallavicini; Enzo Tagliazucchi; Federico Cavanna; Stephanie Muller; Laura Alethia de la Fuente; Federico Zamberlan; Matías Palmucci; Lucie Janeckova; Martin Kuchar
Journal:  Transl Psychiatry       Date:  2022-08-02       Impact factor: 7.989

7.  Cannabidiol (CBD) and other drug use among young adults who use cannabis in Los Angeles.

Authors:  Ekaterina V Fedorova; Carolyn F Wong; Janna Ataiants; Ellen Iverson; Bridgid M Conn; Stephen E Lankenau
Journal:  Drug Alcohol Depend       Date:  2021-02-22       Impact factor: 4.492

8.  The Algorithms of Mindfulness.

Authors:  Johannes Bruder
Journal:  Sci Technol Human Values       Date:  2021-06-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.